_version_ 1783575528294318080
author Alivernini, Stefano
Petricca, Luca
Perniola, Simone
Fedele, Anna Laura
Gigante, Maria Rita
Capacci, Annunziata
Paglionico, Annamaria
Varriano, Valentina
De Lorenzis, Enrico
Lanzo, Lucia
Melpignano, Fabrizio
Rubortone, Pietro
Tanti, Giacomo
Tur, Carlo
Bruno, Dario
Gigante, Laura
Natalello, Gerlando
Verardi, Lucrezia
Di Mario, Clara
Tolusso, Barbara
Mirone, Luisa
Lizzio, Marco Maria
Zoli, Angelo
Peluso, Giusy
Bosello, Silvia Laura
Gremese, Elisa
author_facet Alivernini, Stefano
Petricca, Luca
Perniola, Simone
Fedele, Anna Laura
Gigante, Maria Rita
Capacci, Annunziata
Paglionico, Annamaria
Varriano, Valentina
De Lorenzis, Enrico
Lanzo, Lucia
Melpignano, Fabrizio
Rubortone, Pietro
Tanti, Giacomo
Tur, Carlo
Bruno, Dario
Gigante, Laura
Natalello, Gerlando
Verardi, Lucrezia
Di Mario, Clara
Tolusso, Barbara
Mirone, Luisa
Lizzio, Marco Maria
Zoli, Angelo
Peluso, Giusy
Bosello, Silvia Laura
Gremese, Elisa
author_sort Alivernini, Stefano
collection PubMed
description
format Online
Article
Text
id pubmed-7454831
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-74548312020-08-31 No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic Alivernini, Stefano Petricca, Luca Perniola, Simone Fedele, Anna Laura Gigante, Maria Rita Capacci, Annunziata Paglionico, Annamaria Varriano, Valentina De Lorenzis, Enrico Lanzo, Lucia Melpignano, Fabrizio Rubortone, Pietro Tanti, Giacomo Tur, Carlo Bruno, Dario Gigante, Laura Natalello, Gerlando Verardi, Lucrezia Di Mario, Clara Tolusso, Barbara Mirone, Luisa Lizzio, Marco Maria Zoli, Angelo Peluso, Giusy Bosello, Silvia Laura Gremese, Elisa Rheumatology (Oxford) Letters to the Editor Oxford University Press 2020-09 2020-07-29 /pmc/articles/PMC7454831/ /pubmed/32728733 http://dx.doi.org/10.1093/rheumatology/keaa388 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letters to the Editor
Alivernini, Stefano
Petricca, Luca
Perniola, Simone
Fedele, Anna Laura
Gigante, Maria Rita
Capacci, Annunziata
Paglionico, Annamaria
Varriano, Valentina
De Lorenzis, Enrico
Lanzo, Lucia
Melpignano, Fabrizio
Rubortone, Pietro
Tanti, Giacomo
Tur, Carlo
Bruno, Dario
Gigante, Laura
Natalello, Gerlando
Verardi, Lucrezia
Di Mario, Clara
Tolusso, Barbara
Mirone, Luisa
Lizzio, Marco Maria
Zoli, Angelo
Peluso, Giusy
Bosello, Silvia Laura
Gremese, Elisa
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
title No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
title_full No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
title_fullStr No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
title_full_unstemmed No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
title_short No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
title_sort no higher risk of respiratory symptoms in italian rheumatological patients under il-6r-inhibitor therapy in sars-cov-2 pandemic
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454831/
https://www.ncbi.nlm.nih.gov/pubmed/32728733
http://dx.doi.org/10.1093/rheumatology/keaa388
work_keys_str_mv AT aliverninistefano nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT petriccaluca nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT perniolasimone nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT fedeleannalaura nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT gigantemariarita nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT capacciannunziata nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT paglionicoannamaria nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT varrianovalentina nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT delorenzisenrico nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT lanzolucia nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT melpignanofabrizio nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT rubortonepietro nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT tantigiacomo nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT turcarlo nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT brunodario nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT gigantelaura nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT natalellogerlando nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT verardilucrezia nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT dimarioclara nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT tolussobarbara nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT mironeluisa nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT lizziomarcomaria nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT zoliangelo nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT pelusogiusy nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT bosellosilvialaura nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic
AT gremeseelisa nohigherriskofrespiratorysymptomsinitalianrheumatologicalpatientsunderil6rinhibitortherapyinsarscov2pandemic